Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 124 of 124 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 10/21/23
Due: 10/21/24
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 03/15/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 05/07/07
End: 04/01/09
Due: 04/01/10
Phase: N/A
Priority: Normal
Start: 08/23/24
End: 06/30/30
Due: 06/30/31
Phase: N/A
Priority: Normal
Start: 09/30/05
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 03/15/18
Due: 03/15/19
PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 03/11/24
End: 03/31/27
Due: 03/31/28
Phase: N/A
Priority: Normal
Start: 03/30/17
End: 10/31/22
Due: 10/31/23
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 02/21/23
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 09/25/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/31/99
End: 12/31/07
Due: 12/31/08
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 12/31/18
Due: 12/31/19
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 02/28/17
Due: 02/28/18
Phase: N/A
Priority: Normal
Start: 12/01/17
End: 09/24/18
Due: 09/24/19
Phase: N/A
Priority: Normal
Start: 10/31/06
End: 10/31/07
Due: 10/31/08
Phase: N/A
Priority: Normal
Start: 06/30/24
End: 12/31/27
Due: 12/31/28